Pioglitazone is Effective Therapy for Elderly Patients with Type 2 Diabetes Mellitus

Author： Rajagopalan R.   Perez A.   Ye Z.   Khan M.   Murray F.T.  

Publisher： Adis International

ISSN： 1170-229X

Source： Drugs & Aging, Vol.21, Iss.4, 2004-01, pp. : 259-271

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pioglitazone Improves Diabetic Dyslipidaemia in Patients with Type 2 Diabetes Mellitus with or without Lipid-Lowering Therapy

By Schöfl Christof  

Clinical Drug Investigation, Vol. 25, Iss. 5, 2005-01 ,pp. : 341-345

Adis International

Access to resources Recommend Favorite

Pioglitazone: a valuable component of combination therapy for type 2 diabetes mellitus

By Papanas Nikolaos   Katsiki Niki   Hatzitolios Apostolos I   Maltezos Efstratios  

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 10, 2011-07 ,pp. : 1457-1461

Informa Healthcare

Access to resources Recommend Favorite

Pioglitazone pays dividends in type 2 diabetes mellitus

By  

Inpharma, Vol. 1, Iss. 1612, 2007-01 ,pp. : 3-4

Adis International

Access to resources Recommend Favorite

Pioglitazone pays dividends in type 2 diabetes mellitus

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 540, 2007-01 ,pp. : 3-4

Adis International

Access to resources Recommend Favorite

Clinical Analysis of Elderly Patients with Elderly-onset Type 2 Diabetes Mellitus in China: Assessment of Appropriate Therapy

By Wang Y   Qin M-Z   Liu Q   Liu Q   Chang Z-W  

The Journal of International Medical Research, Vol. 38, Iss. 3, 2010-06 ,pp. : 1134-1141

Field House Publishing

Access to resources Recommend Favorite